Visionary Holdings

GV

Market cap $5.85M

HONG KONG , Nov. 10, 2025 /PRNewswire/ -- Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited, has official launch of its medical-grade stem cell anti-aging product line, initially targeting the Chinese mainland and broader Asian markets. This launch marks a major milestone following GV's entry into the stem cell and medical aesthetics sector earlier this year, as well as its strategic partnership and global technology licensing agreement with Jiangsu Yike Regenerative Medicine Co., Ltd.

TORONTO , Nov. 4, 2025 /PRNewswire/ -- At 10:00 a.m. (Eastern Time, USA) on November 3, 2025, Visionary Holdings Inc. (hereinafter referred to as the "Company", NASDAQ: GV) successfully convened the First Meeting of the Fourth Board of Directors.

TORONTO , Oct. 31, 2025 /PRNewswire/ -- Visionary Holdings Inc. (hereinafter referred to as the "Company"; a diversified enterprise registered in Ontario, Canada and listed on the Nasdaq Capital Market under the ticker symbol: GV) successfully held its 2025 Annual General Meeting (AGM) via Zoom video conference from 10:00 a.m. to 12:00 p.m.

TORONTO , Oct. 25, 2025 /PRNewswire/ -- Visionary Holdings Inc. (Nasdaq: GV) ("Visionary" or the "Company"), a private education service provider integrating technology and innovation, today announced that on August 5, 2025, it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to its delay in filing its Annual Report on Form 20-F for the fiscal year ended March 31, 2025 (the "Form 20-F"). The Nasdaq letter has no immediate effect on the listing or trading of the Company's common shares on the Nasdaq Capital Market.

TORONTO , Oct. 22, 2025 /PRNewswire/ -- Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced the signing of a strategic cooperation agreement with Jiangsu Yike Regenerative Medical Technology Co., Ltd. ("Yike") to jointly establish Visionary Yike Stemcell Technologies Inc., a Canada-based joint venture dedicated to advancing stem cell research, clinical application, and commercialization worldwide.

TORONTO, Oct. 17, 2025 /PRNewswire/ -- Visionary Holdings Inc. (Nasdaq: GV, hereinafter referred to as "Visionary" or the "Company"), a Nasdaq-listed enterprise, announced today that it has completed the equity adjustment of "Sikang (Guangzhou) Health Industry Investment Co., Ltd." (hereinafter referred to as the "Joint Venture Company"), a joint venture established with Guangzhou Sikang Investment Holding Co., Ltd.

TORONTO , Oct. 13, 2025 /PRNewswire/ -- Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its wholly owned subsidiary, Visionary Holdings (Asia) Limited, has entered into a Global Product and Technology Licensing Agreement with Jiangsu Yike Regenerative Medicine Co., Ltd. ("Yike"). The agreement grants GV the worldwide rights to apply Yike's breakthrough stem cell technology, which has demonstrated significant potential in advancing treatments for diabetes and with other regenerative medicine innovations.

TORONTO , Oct. 8, 2025 /PRNewswire/ -- Visionary Holdings Inc. ("GV" or the "Company"), is pleased to announce it has mailed a Notice of Meeting and Management Information Circular to Shareholders of record as of September 12, 2025 in connection with the Annual Meeting of Shareholders of the Company to be held on Wednesday, October 29, 2025, at 10:00 a.m. (Eastern Time).

HONG KONG , Sept. 24, 2025 /PRNewswire/ -- Visionary Holdings (Asia) Limited, a wholly owned subsidiary of Visionary Holdings Inc. (Nasdaq: GV), today announced the signing of a strategic cooperation agreement with Qianxin Bocheng (Jiangsu) Technology Development Co., Ltd.

NEW YORK CITY, NY / ACCESS Newswire / September 17, 2025 / Visionary Holdings Inc. (NASDAQ:GV) ("GV" or the "Company"), a technology-driven multinational enterprise, today announced that it has entered into a strategic partnership with Jiangsu Yike Regenerative Medicine. ("Yike "), a leading regenerative medical research institute in China.